Gemeprost

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Gemeprost
Gemeprost.svg
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Pessary
ATC code
Identifiers
Synonyms methyl (E)-7-[(1R,2S,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4,4-dimethyl-oct-1-enyl]-5-oxo-cyclopentyl]hept-2-enoate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ECHA InfoCard 100.058.869
Chemical and physical data
Formula C23H38O5
Molar mass 394.545 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Gemeprost (16, 16-dimethyl-trans-delta2 PGE1 methyl ester) is an analogue of prostaglandin E1.

Clinical use[edit]

It is used as a treatment for obstetric bleeding.

It is used with mifepristone to terminate pregnancy up to 24 weeks gestation.[1]

Side effects[edit]

Vaginal bleeding, cramps, nausea, vomiting, loose stools or diarrhea, headache, muscle weakness; dizziness; flushing; chills; backache; dyspnoea; chest pain; palpitations and mild pyrexia. Rare: Uterine rupture, severe hypotension, coronary spasms with subsequent myocardial infarctions.

References[edit]

  1. ^ Bartley J, Brown A, Elton R, Baird DT (October 2001). "Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation". Human reproduction (Oxford, England). 16 (10): 2098–102. PMID 11574498. doi:10.1093/humrep/16.10.2098. Retrieved 2008-10-29.